Researcher comment: The KEYNOTE-604 trial | Charles Rudin

(5:2)

Researcher comment: The TheraP trial | Michael Hofman

(4:25)

Researcher comment: The KEYNOTE-355 trial | Javier Cortes

(5:37)

Researcher comment: The KEYNOTE-146/Study 111 trial | Chung-Han Lee

(4:58)

Researcher comment: Final analysis of KEYNOTE-189 | Delvys Rodriguez-Abreu

(4:52)

Researcher comment: The 2-year outcomes of the DiRECT trial | Roy Taylor

(6:45)

Researcher comment: The PrE0505 study | Patrick Forde

(6:24)

Researcher comment: The SAVOIR trial | Toni Choueiri

(4:24)

ተደብቆ የቆየው የጸሎት ቀመር | የ 7 ቁጥር ምስጢር | ANCIENT PRAYER CODE | ዶርሮዳስታደሰ - Dr. Rodas Tadese | QEBETO

(17:15)

ዓዳም የምድርን ኃይል የተጠቀመበት ጥበብ | የባዶ እግር ጉዞ ድብቅ ጥቅም | ዶርሮዳስታደሰ - Dr. Rodas Tadese | QEBETO

(19:22)

Budget 2025: Impact on Research \u0026 Future of Scholars in India! All 'Bout Research #budget2025

(9:46)

Euclid, what the first images of the Cosmos reveal by Jean-Charles Cuillandre

(1:4:54)

How to read a Research Paper ? Made easy for young researchers.

(8:39)

Iranian Researchers Claim Black Biblical Israelites Were the Original Hebrews.

(28:58)

I tested DeepSeek vs. OpenAI-o1 for data science tasks: Here’s what I found.

(15:12)

NEW OpenAI Deep Research Agents are INSANE 🤯

(15:6)

Google Gemini Deep Research + NotebookLM - Ultimate AI Combo

(13:27)

Abraham El Jaguar talks old world \u0026 sci-fi with researcher and philosopher Lucius Aurelian!

(1:19:44)

Researcher comment: SELECT-PsA-2 | Philip Mease

(6:18)

Researcher comment: The CONTROL trial | Laura Coates

(4:36)

Researcher comment: CheckMate 817 trial of nivolumab–ipilimumab | Fabrice Barlesi

(3:32)

Researcher comment: Initial data from CCC19 | Jeremy Warner

(14:41)

Researcher comment: Updated KEYNOTE-426 data | Elizabeth Plimack

(1:46)

Researcher comment: The BLASST-1 trial | Shilpa Gupta

(3:16)

Researcher comment: 5-year KEYNOTE-001 results | Edward Garon

(4:13)

Researcher comment: SELECT-PsA-1 | Frank Behrens

(7:49)

Researcher comment: The SPIRIT-P3 study | Laura Coates

(4:2)

Researcher comment: Perioperative durvalumab for locally advanced RCC | Moshe Ornstein

(5:18)

Researcher comment: The FINCH 1 trial

(7:20)